Occidental Asset Management »

Halozyme Therapeutics shares owned by Occidental Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Occidental Asset Management from 13F filings

Historical chart of Occidental Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Occidental Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Occidental Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $457k 6.8k 67.30
2025-09-30 $568k 7.7k 73.34
2025-06-30 $403k 7.7k 52.02

More positions owned by Occidental Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (SPIB)
Spdr Series Trust State Street Spd (SPSB)
Ishares Tr Rus 1000 Grw Etf (IWF)
Flexshares Tr Cre Slct Bd Fd (BNDC)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Rus Mdcp Val Etf (IWS)
Ishares Tr Rus Md Cp Gr Etf (IWP)

View all positions for Occidental Asset Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics